Telemonitoring of Pregnancies Complicated With Gestational Diabetes Mellitus.

Launched by HASSELT UNIVERSITY · Feb 8, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how telemonitoring, or remote health monitoring using technology, can improve care for pregnant women with gestational diabetes mellitus (GDM). GDM is a type of diabetes that can develop during pregnancy, and the goal of this study is to use telemonitoring to help doctors keep a closer watch on blood sugar levels. By doing this, the hope is to respond more quickly if there are any problems, ultimately leading to better health outcomes for both mothers and their babies.

To participate in this study, women must be diagnosed with gestational diabetes, be at least 20 weeks pregnant, and be able to communicate in Dutch. They also need to have a smartphone, as this will be used for monitoring. If you join the trial, you can expect to use telemonitoring tools to track your health regularly, which may help ensure a healthier pregnancy. This trial is currently recruiting participants, and your involvement could contribute to improving care for future mothers facing similar challenges.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of gestational diabetes mellitus
• • Minimum 20 weeks of pregnancy
• • Is proficient in Dutch
• • Signing the Informed Consent
• Exclusion Criteria:
• • \<20 weeks of pregnancy
• • Diagnosis of type 1 diabetes
• • Congenital anomalies identified in the fetus
• • Participant does not own a smartphone